At the time of writing, CorMedix Inc [CRMD] stock is trading at $8.42, down -1.75%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRMD shares have gain 1.32% over the last week, with a monthly amount drifted -18.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CorMedix Inc [NASDAQ: CRMD] stock has seen the most recent analyst activity on August 26, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $13. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on August 10, 2023, and set its price target to $6. On February 17, 2021, Needham initiated with a Buy rating and assigned a price target of $31 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $22 on September 29, 2020. Truist initiated its recommendation with a Buy and recommended $20 as its price target on September 21, 2020. B. Riley FBR started tracking with a Buy rating for this stock on December 18, 2019, and assigned it a price target of $48. In a note dated March 26, 2019, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $3 to $15.
For the past year, the stock price of CorMedix Inc fluctuated between $2.89 and $13.85. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. CorMedix Inc [NASDAQ: CRMD] shares were valued at $8.42 at the most recent close of the market. An investor can expect a potential return of 6.89% based on the average CRMD price forecast.
Analyzing the CRMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -4.06%, Pretax Profit Margin comes in at -3.78%, and Net Profit Margin reading is -3.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.59, Equity is -0.79 and Total Capital is -0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.21 points at the first support level, and at 8.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.59, and for the 2nd resistance point, it is at 8.76.
Ratios To Look Out For
It is important to note that CorMedix Inc [NASDAQ:CRMD] has a current ratio of 3.96. Also, the Quick Ratio is 3.60, while the Cash Ratio stands at 1.91. Considering the valuation of this stock, the price to sales ratio is 40.26, the price to book ratio is 8.30.
Transactions by insiders
Recent insider trading involved Mistry Erin, EVP, Chief Commercial Officer, that happened on Oct 31 ’24 when 1500.0 shares were purchased. EVP, Hurlburt Elizabeth completed a deal on Nov 14 ’24 to sell 0.14 million shares. Meanwhile, Officer Hurlburt Elizabeth bought 0.14 million shares on Nov 14 ’24.
